Pros | ![]() Lower expense ratio. ![]() Beats FD returns for both 3Y & 5Y duration. | |||
Cons | ![]() 3Y returns in the bottom 25% of the category. |
INDMoney rank | 5/8 | |||
Category,Subcateogry | Equity,Sector - Healthcare | |||
Fund Age | 6 Years | |||
Fund Size | 2667 Cr | |||
Min Investment | SIP ₹99 Lumpsum ₹5000 | |||
Expense Ratio | 0.61% | |||
Exit Load | 1% | |||
Benchmark Index | BSE Healthcare TR INR |
No of Holdings | 34 | |||
Top 5 Holdings | Sun Pharmaceuticals Industries Ltd (11.9%) Aurobindo Pharma Ltd (7.12%) Cipla Ltd (6.91%) Divi's Laboratories Ltd (6.6%) Lupin Ltd (6.2%) | |||
No of Sectors | 3 | |||
Top 3 Sectors | Health (98.7%) Basic Materials (1.3%) Industrial (0%) | |||
Equity % | 99.55% | |||
Debt % | - | |||
P/E | 34.28 | |||
P/B | 5.04 | |||
Credit Quality | - | |||
Modified Duration | - | |||
YTM | - |
1-Month Return | 1.12% | |||
3-Month Return | -0.92% | |||
6-Month Return | -1.32% | |||
1-Year Return | 23.51% | |||
3-Year Return | 20.08% | |||
5-Year Return | 24.98% |
Sharpe | 0.76 | |||
Alpha | -0.36 | |||
Beta | 0.98 | |||
Standard Deviation | 17.14 | |||
Information Ratio | -0.24 |
Description | Mirae Asset Healthcare Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | |||
Managers | Vrijesh Kasera |